Safety and efficacy of cefprozil as part of a parenteral-oral antibiotic regimen for the treatment of suppurative skeletal infections in children.
Trujillo
M
M
Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas 75235-9063, USA.
Ehrett
S
S
Hoyt-Sehnert
M J
MJ
Shelton
S
S
McCracken
G H
GH
D000284:Administration, Oral; D001424:Bacterial Infections / Q000188:drug therapy*; D001707:Biopsy, Needle; D001847:Bone Diseases / Q000188:drug therapy* / Q000382:microbiology*; D002511:Cephalosporins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy* / Q000382:microbiology*; D007596:Joints / Q000382:microbiology; D008826:Microbial Sensitivity Tests; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus; D000097670:Cefprozil
D002511:Cephalosporins; D000097670:Cefprozil